HEAE:LSE:LSE-SPDR® MSCI Europe Health Care UCITS ETF GBP (GBP)

ETF | Others |

Last Closing

USD 186.76

Change

-0.56 (-0.30)%

Market Cap

USD 0.64B

Volume

1.00K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R15:LSE SoftBank Group Corp.

+180.00 (+2.15%)

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

+280.00 (+3.37%)

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

-1.50 (-0.80%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.04 (-0.27%)

USD 642.91B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.04 (-0.24%)

USD 636.40B
0R1I:LSE NVIDIA Corp.

+5.05 (+0.54%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+5.75 (+0.28%)

USD 320.04B
0QZK:LSE Coca-Cola Co.

+0.40 (+0.63%)

USD 266.08B
0QZO:LSE 0QZO

+1.30 (+1.27%)

USD 258.54B

ETFs Containing HEAE:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.81% 82% B 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.81% 82% B 73% C
Trailing 12 Months  
Capital Gain 3.59% 38% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.59% 36% F 48% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.89% 42% F 50% F
Dividend Return 1.89% 40% F 49% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.66% 91% A- 96% N/A
Risk Adjusted Return 51.67% 69% C- 79% B-
Market Capitalization 0.64B 74% C 63% D

Annual Financials (GBP)

Quarterly Financials (GBP)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.